Uncommon ALK fusion partners in advanced ALK-positive non-small-cell lung cancer.
Journal of Clinical Oncology(2018)
摘要
8561Background: The variants affect the efficacy of crizotinib in echinoderm microtubule protein-like-4 (EML4)- anaplastic lymphoma kinase (ALK) fusion-positive non–small-cell lung cancers (NSCLCs)...
更多查看译文
关键词
Crizotinib,Anaplastic lymphoma kinase,Lung cancer,Cancer research,Lung,Microtubule,Medicine,ALK-Positive,Non small cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要